efgartigimod
argenx
['advance iv', 'argenx']
this is aaron place, medical research liaison, emerging from the #ash22 poster room. head over to learn more about our data from the advance iv study for people with primary #itp. 
We’re a global immunology company using co-creation to develop potential therapies for people with severe autoimmune diseases and cancer.